The effect of 1×10⁶ MSCs transplantation on renal function and morphology after I/R injury. by Jieru Cai (411450)

“…<p>(A) Compared with control group (5.22±0.43 mg/dl), both TV group (4.78±0.88 mg/dl) and CA group (4.48±0.95 mg/dl) seemed to derive at least some benefits from cell therapy, as shown by a trend towards a reduced Scr level, although the difference between TV and control group was no statistically significant. …”

The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa by Lesong Conteh (231114)

“…</p><h3>Methods</h3><p>We analysed data from 5 countries in sub-Saharan Africa using a total of 5 different IPTi drug regimens; SP, mefloquine (MQ), 3 days of chlorproguanil-dapsone (CD), SP plus 3 days of artesunate (SP-AS3) and 3 days of amodiaquine-artesunate (AQ3-AS3).The cost per malaria episode averted and cost per Disability-Adjusted Life-Year (DALY) averted were modeled using both trial specific protective efficacy (PE) for all IPTi drugs and a pooled PE for IPTi with SP, malaria incidence, an estimated malaria case fatality rate of 1.57%, IPTi delivery costs and country specific provider and household malaria treatment costs.…”

Sertoli cell-specific ablation in adulthood. by Diane Rebourcet (153547)

“…(I) Sertoli cell ablation is mirrored by a decrease in Sertoli cell specific transcript expression: <i>Dhh</i>, <i>Fshr</i> and <i>Wt1</i> (one-way ANOVA n = 5–9, ***P<0.001). …”

Characterization of <i>ob/ob</i>-luc mice. by Manishkumar Patel (627143)

“…<p>A) Weight increases significantly with age in <i>ob/ob</i>-luc mice consistent with the original <i>ob/ob</i> mouse model on the B6 black background. …”

Data_Sheet_1_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_7_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_2_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_8_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_6_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_3_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Data_Sheet_4_Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019.PDF by Ozra Tabatabaei-Malazy (10224488)

“…The highest increase and decrease in the mortality rate were estimated in Morocco 21.8% (−8.9 to 51.6) and Kuwait −41.5% (−51.2 to −29.1). …”

Antisera competition to different mAbs. by Rachel P. J. Lai (172124)

“…The fluorescent signal of Europium is proportional to residual mAb binding, relative to the prebleed controls. A decrease in residual mAb binding indicated an increase in specificity of the antiserum for the epitope site. …”

Sporozoite speed is optimized for efficient spread. by Janina Kristin Hellmann (217258)

“…(E, F) Weighted mean free path length (MFPL) for all sporozoites migrating in 3 µm arrays (E) decreases with increasing speed, while for those migrating in 5 µm arrays (F) it increases at the fastest speeds.…”

DataSheet1_Baseline of Surface and Column-Integrated Aerosol Loadings in the Pearl River Delta Region, China.DOCX by Xuehua Fan (12688418)

“…Significant decreases in PM₁₀, PM_2.5, and PM₁ mass concentrations are observed with magnitudes up to −2.13, −1.82, and −1.37 yr⁻¹, respectively, at a 95% confidence level. …”

Mitoflashes are switched to lower ΔF/F₀ amplitude and R-type mitoflashes in dystrophin morphants. by Meiling Zhang (352540)

“…Data were reported as median with interquartile range at 1/4, 1/2 and 3/4 of the data, respectively (Fig 5A, E-G) and mean ± SEM (for Fig 5B-D). Unpaired t test with Welch’s correction (Fig 5A-D) and Mann-Whitney test (Fig 5E and G) was applied to determine statistical significance of the differences. **: p <0.01 versus wild-type group, ***: p <0.0001 versus wild-type group.…”

Formation, Structural Variety, and Impact of Antiphase Boundaries on Li Diffusion in LiCoO₂ Thin-Film Cathodes by Phuong-Vu Ong (3909100)

Erratum: Stress Impairs Synaptic Plasticity in Triple-Transgenic Alzheimer's Disease Mice: Rescue by Ryanodine by Grigoryan G. (4273339)

Increase of soluble Sema4D and reorganization of Plexin-B1 receptor during vaginal development. by Takuji Ito (566032)

“…*<i>P</i><0.05, ANOVA. (C) The ratio of membrane-bound Sema4D to β-actin significantly decreases in 5-week-old vaginal tissue. …”

Chronic neuronal activity inhibition by TTX reduces extracellular amyloid in APP^Swe/PS1^L166P mice. by Francesca Montarolo (171473)

“…The analysis showed an increase of plaque number (<b>A</b>; <b>C</b>) but not of plaque size (<b>B</b>; <b>D</b>) after TTX administration in hippocampus (<b>A</b>; <b>B</b>) and entorhinal cortex (<b>C</b>; <b>D</b>) (n = 5 in each group, three sections per mouse, three frames per section, <i>* P</i><0.05, *** <i>P</i><0.001, Student’s <i>t</i>-test). …”

Analysis of OBs by Haydn M Prosser (40070)